Menu

Website Search

Tagrissohcp.com

tagrissohcp.com
Visit tagrissohcp.com

  • 1 year ago

    Last scanned

  • 8 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Tagrissohcp.com

Visit tagrissohcp.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Treatment for Resectable and Metastatic EGFRm NSCLC – TAGRISSO® (osimertinib)

Learn more about TAGRISSO® (osimertinib), a targeted therapy for the first-line treatment of metastatic EGFRm non-small cell lung cancer and for resectable EGFRm NSCLC.

Tagrissohcp.com thumbnail
Tagrissohcp.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for tagrissohcp.com: 13.32.182.28, 13.32.182.68, 13.32.182.118, 13.32.182.121. Moreover, DNS used with this website include ns-1515.awsdns-61.org, ns-1993.awsdns-57.co.uk, ns-505.awsdns-63.com, ns-558.awsdns-05.net. Subnet identifier ranges from 18.64.0.0 to 18.67.255.255. Classless Inter-Domain Routing (CIDR) is 18.64.0.0/14. ARIN net type is Reallocated.

  • 1 year ago

    Last scanned

  • 8 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of tagrissohcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2023-09-30. According to open source data, you can reach the owner at dns-admin@cscglobal.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Sweden.

  • osimertinib
  • tagrisso
  • tagrisso pi
  • osimertinib mechanism of action
  • tagrisso mechanism of action

Websites similar to tagrissohcp.com

Tagrissohcp.com friends